Joseph Depetro, MD
Family Medicine · Wellsburg, WVNPI 1083764666
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 381 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- AbbVie$700
- Pfizer$465
- AstraZeneca$454
- Amgen$423
- Mylan Specialty L.p.$386
- plus $4K from 29 others
What the payments were for
- Travel & lodging$50%
- Food & beverage$6,80896%
- Education$2684%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 68 | $1,124 |
| AbbVie(2 entities) | 43 | $700 |
| Pfizer | 24 | $465 |
| AstraZeneca | 28 | $454 |
| Amgen | 20 | $423 |
| Mylan Specialty L.p. | 23 | $386 |
| Astellas Pharma US Inc | 10 | $361 |
| Sanofi-aventis U.S. LLC | 16 | $357 |
| Novo Nordisk | 17 | $295 |
| Johnson & Johnson | 14 | $282 |
| Boehringer Ingelheim | 15 | $260 |
| Exact Sciences | 9 | $190 |
| Merck | 11 | $183 |
| Valeritas, Inc. | 3 | $180 |
| Novartis | 10 | $160 |
| Daiichi Sankyo Inc. | 9 | $148 |
| Bayer | 7 | $140 |
| GSK | 2 | $134 |
| Lundbeck LLC | 7 | $130 |
| Amarin Pharma, Inc. | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $87 |
| Sanofi Pasteur Inc. | 4 | $67 |
| Viatris Specialty LLC | 3 | $52 |
| Amneal Pharmaceuticals LLC | 2 | $51 |
| Sunovion Pharmaceuticals Inc. | 5 | $50 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Ultragenyx Pharmaceutical Inc. | 3 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Corcept Therapeutics | 2 | $42 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Kyowa Kirin, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Seqirus USA Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,082 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 328 | $206,744 |
| OzempicSemaglutide | 97 | $125,962 |
| MounjaroTirzepatide | 42 | $51,082 |
| JanuviaSitagliptin Phosphate | 60 | $42,115 |
| JardianceEmpagliflozin | 27 | $25,468 |
| EntrestoSacubitril/Valsartan | 25 | $23,820 |
| FarxigaDapagliflozin Propanediol | 16 | $20,384 |
| TradjentaLinagliptin | 36 | $18,603 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 16 | $15,056 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $14,486 |
| RexultiBrexpiprazole | 35 | $12,539 |
| XareltoRivaroxaban | 58 | $12,496 |
| OxycontinOxycodone Hcl | 13 | $7,628 |
| Levothyroxine Sodium | 696 | $6,608 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 20 | $5,881 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $465 | $206,744328 claims |
| Novo NordiskOzempic | $295 | $125,96297 claims |
| Lilly USA, LLCMounjaro | $1,124 | $51,08242 claims |
| Boehringer IngelheimJardiance, Tradjenta | $260 | $44,07163 claims |
| MerckJanuvia | $183 | $42,11560 claims |
| NovartisEntresto | $160 | $23,82025 claims |
| GSKTrelegy Ellipta, Arexvy | $134 | $20,93636 claims |
| AstraZenecaFarxiga | $454 | $20,38416 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $357 | $14,48612 claims |
| Johnson & JohnsonXarelto | $282 | $12,49658 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $51 | $6,608696 claims |
| AbbVieSynthroid | $700 | $1,84038 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Wellsburg
- Julie DetempleSouth Charleston$129K
- John CornellHuntington$68K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
- David HessBridgeport$20K
- Cherry LobatonMartinsburg$19K
- Melissa GamponiaCharleston$18K
- Stephen MascioFollansbee$17K
- Kenneth AdkinsSouth Charleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.